Hi, 1PERCENT here. Roche Holding, a Swiss multinational biopharma company. It is like the Apple of biopharma. There were only 3 pull backs greater than 30% in the history of the stock. 2002 ~ 2003: -45.33% 2006 ~ 2011: -52.40% 2014 ~ 2018: -30.24% 2022 ~ present: -44.89% It is at the support zone that initiated the +95% move up from 2018 to 2022, and also is...
How low will eth go? Nobody knows. Probably double bottoms as it has done that historically. The HNS neckline retests have all failed, so there's usually only the down direction from this point.
Good news combined with a perfect breakout at 357. Just needs a bit more volume.
Roche making higher lows inside a descending broadening wedgem, while showing signs of accumulation with a sell wall at 326.85$. The bullish engulfing candles on Jan 11 and the Marubozu on Feb 4 show that the demand for this asset is high at the previous Peak back in December 2014. The fact that there is also MACD hidden bullish divergence on the daily and the...
The market is bullish and the idea is to invest in the Market direction. Fundamental Analysis Info: Britain is in talks with Swiss drugmaker Roche Holding AG (ROG.S) to buy an accurate COVID-19 antibody test, following the lead of the European Union and United States, which had already given preliminary approval to the tests.
ROG Broken down from key support area, re-tested it & seems falling down now. It also had massive insider selling. We think it will decline around 50. Break of 54.73 will be a good entry point & On the option side we are looking for Dec 55 put at $3 You can check our detailed analysis on ROG in the trading room/ Executive summery link here- www.youtube.com Time...